Table 2.
Comparison of annual diabetes costs per patient in Spain
| Mata et al. (CODE 2) | Oliva et al. | Ballesta et al. | Lopez Bastida et al. | |
|---|---|---|---|---|
| Publication year |
2002 |
2004 |
2006 |
2002 |
| Reference year |
1998 |
2002 |
1999 |
1998 |
| Type of study |
National, observational, prevalence and bottom-up approach. |
National, prevalence and top-down approach. |
Regional, observational, prevalence and bottom-up approach. |
Regional, prevalence and top-down approach. |
| Type of costs |
Direct health care costs |
Direct health care costs |
Direct health care costs and productivity losses (human capital) |
Direct health care costs and productivity losses (human capital) |
| Sources of resources used |
Primary data. |
Primary and secondary data. |
Primary data. |
Primary data. |
| Diabetes Type |
Type II |
Type I & II |
Type II |
Type I & II |
| Age |
30-89 years |
18+ years |
14+ years |
0-99 years |
| Total costs |
€1305 |
€1290-1476 |
€4278 |
€758 |
| Direct: €2504 |
Direct: €470 |
|||
| Productivity €1774 |
Productivity: €288 |
|||
| Drug costs |
€554 |
€636 |
€851 |
€179 |
| Hospitalization costs |
€417 |
€512 |
€1005 |
€183 |
| % inpatient costs |
59.8% |
37% |
39% |
38% |
| % outpatient costs |
18.5% |
17% |
28% |
23% |
| % drug costs | 21.7% | 46% | 33% | 39% |